Abstract
The authors assessed the ability of the neurophilin compound, timcodar dimesylate, to accelerate the return of epidermal nerve fiber density (ENFD) after a standardized nerve injury in a randomized double blind, placebo controlled trial. While there was no difference in the regeneration rate between the treatment and placebo arms, the baseline ENFD (p = 0.006), height (p = 0.02), and race (p = 0.03) were associated with the regeneration rate.
Original language | English (US) |
---|---|
Pages (from-to) | 259-261 |
Number of pages | 3 |
Journal | Neurology |
Volume | 66 |
Issue number | 2 |
DOIs | |
State | Published - Jan 2006 |
ASJC Scopus subject areas
- Clinical Neurology